Yenzym antibodies, LLC:1347960 [23-006476]

Ended Purchase Order Awarded

Contract number
75N98B23P00021
Awardee
Awarding agency
Obligated
$10,875

Award facts

Contract value 100% obligated
$10,875.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325414 Biological Product (except Diagnostic) Manufacturing
PSC
6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Brisbane, CA 94005, USA

Award details come from SAM.gov/FPDS.

About this award

The Department of Health and Human Services' National Institutes of Health National Eye Institute awarded a $10,875 firm fixed price purchase order to Yenzym Antibodies, LLC of Brisbane, California. Under the contract, Yenzym Antibodies will provide antibodies to the NIH/NEI over the one year period of performance from September 2023 through September 2024. As a small biotech firm, Yenzym specializes in developing research tools for vision science and will support the NIH/NEI's efforts to better understand and treat eye diseases through its contract deliverables. No subcontractors or set aside designations were identified.

Quick answers

Who was awarded contract 75N98B23P00021?

75N98B23P00021 was awarded to Yenzym Antibodies, LLC by National Eye Institute (National Institutes of Health) on September 8, 2023.

How much is contract 75N98B23P00021 worth?

The government has obligated $10,875 on 75N98B23P00021.

Was contract 75N98B23P00021 competed?

The extent of competition for 75N98B23P00021 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award